Boiron 

€29.85
72
+€0.35+1.19% Friday 16:35

Statistics

Day High
29.2
Day Low
28.85
52W High
32.25
52W Low
20.85
Volume
176
Avg. Volume
1,132
Mkt Cap
523.72M
P/E Ratio
25.32
Dividend Yield
3.87%
Dividend
1.15

Upcoming

Dividends

3.87%Dividend Yield
Jun 25
€1.2
Jun 24
€1.35
Oct 23
€10.36
Jun 23
€1.1
Jun 22
€0.95
10Y Growth
-2.02%
5Y Growth
3.4%
3Y Growth
5.23%
1Y Growth
N/A

Earnings

18SepExpected
Q1 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
Q1 2025
Q2 2025
0
0.33
0.67
1
Expected EPS
N/A
Actual EPS
N/A

Financials

2.33%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
975.12MRevenue
22.67MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BOI.PA. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
RECKITT BENCKISR GP S/ADR
RBGLY
Mkt Cap51.86B
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products, competing in the homeopathic and natural health sector similar to Boiron.
Pfizer
PFE
Mkt Cap140.15B
Pfizer Inc. is a global pharmaceutical corporation which, through its range of healthcare products and medications, competes in the broader pharmaceutical and healthcare market against companies like Boiron.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson is a multinational corporation that produces pharmaceuticals, medical devices, and consumer packaged goods, directly competing with Boiron in the healthcare and wellness sectors.
GSK
GSK
Mkt Cap94.51B
GlaxoSmithKline plc is a global healthcare company that researches and develops a wide range of medicines and healthcare products, competing with Boiron in the pharmaceutical and healthcare market.
Novartis
NVS
Mkt Cap237.61B
Novartis AG focuses on the discovery, development, and marketing of healthcare products, directly competing with Boiron in the pharmaceutical and health products sector.
Bayer
BAYRY
Mkt Cap30.63B
Bayer AG operates as a life science company with activities in pharmaceuticals, consumer health, and crop science, competing with Boiron in the health and wellness market.
Sanofi
SNY
Mkt Cap124.45B
Sanofi is a global healthcare leader that researches, develops, and distributes therapeutic solutions, competing with Boiron in the healthcare and pharmaceutical sectors.
Merck
MRK
Mkt Cap214.76B
Merck & Co., Inc. is a global healthcare company that produces pharmaceuticals and vaccines, competing with Boiron in the broader healthcare and pharmaceutical market.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie Inc. is a research-based biopharmaceutical company that develops and markets advanced therapies, competing with Boiron in the healthcare and pharmaceutical sectors.
Astrazeneca
AZN
Mkt Cap256.58B
AstraZeneca PLC is a global, science-led biopharmaceutical business that focuses on the discovery, development, and commercialization of prescription medicines, competing with Boiron in the pharmaceutical and healthcare industry.

About

Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary, proprietary, branded homeopathic medicines. Its branded homeopathic medicines include Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive local treatment of benign trauma in the absence of open wounds; Camilia for the treatment of teething problems for babies; and Sédatif PC to treat anxiety and emotional, and minor sleep disorders. The company's homeopathic medicines also comprise Coryzalia for the treatment of cold symptoms and rhinitis; Homéoptic to treat eye discomfort and irritation due to various causes for adults and children; and Homéovox for vocal disorders. In addition, it provides dietary supplement; Dermoplasmine stick, baume, and mousse to treat dry lips and skin; Mag' Nuit, a formula to fall asleep; Arnitrosium for joint pain; Castor Equi Boiron ointment for treatment of cracked skin; and Storinyl, a syrup to treat colds. Further, it offers herbal medicines, such as Canephron to increase the amount of urine and to improve urinary elimination; moisturizing baby milk; and medical devices, including a range of COVID self-tests and rapid antigenic tests. The company offers its products through distribution centers, pharmacies, pharmacy chains, wholesalers, grocery and drugstores, health food stores, and online retail. Boiron SA was founded in 1932 and is headquartered in Messimy, France.
Show more...
CEO
Mr. Thierry Boiron
Employees
2736
Country
FR
ISIN
FR0000061129

Listings

0 Comments

Share your thoughts

FAQ

What is Boiron stock price today?
The current price of BOI.PA is €29.85 EUR — it has increased by +1.19% in the past 24 hours. Watch Boiron stock price performance more closely on the chart.
What is Boiron stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Boiron stocks are traded under the ticker BOI.PA.
Is Boiron stock price growing?
BOI.PA stock has risen by +1.7% compared to the previous week, the month change is a -2.45% fall, over the last year Boiron has showed a +18.92% increase.
What is Boiron market cap?
Today Boiron has the market capitalization of 523.72M
What is Boiron revenue for the last year?
Boiron revenue for the last year amounts to 975.12M EUR.
What is Boiron net income for the last year?
BOI.PA net income for the last year is 22.67M EUR.
Does Boiron pay dividends?
Yes, BOI.PA dividends are paid annual. The last dividend per share was 1.2 EUR. As of today, Dividend Yield (FWD)% is 3.87%.
How many employees does Boiron have?
As of February 16, 2026, the company has 2,736 employees.
In which sector is Boiron located?
Boiron operates in the Health Care sector.
When did Boiron complete a stock split?
Boiron has not had any recent stock splits.
Where is Boiron headquartered?
Boiron is headquartered in Messimy, FR.